166 related articles for article (PubMed ID: 28226009)
1. Cervical cancer screening in Teresina, Piauí, Brazil: evaluation study using data of the Cervical Cancer Information System, 2006-2013.
Damacena AM; Luz LL; Mattos IE
Epidemiol Serv Saude; 2017; 26(1):71-80. PubMed ID: 28226009
[TBL] [Abstract][Full Text] [Related]
2. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
3. Cervical precancerous and cancerous lesions screening using Pap smear test at Provincial Referral Hospital of Bukavu, Eastern DR Congo: profile and recommendations to stakeholders.
Mayeri DG; Kahasha PM; Kibalama IB; Mongane J; Louguè M; Birindwa EK; Mwimangire SC; Kikuru CK; Materanya JM; Bisimwa YK; Kasago B; Mukengeshai LM
Pan Afr Med J; 2024; 47():57. PubMed ID: 38646136
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital.
Lertcharernrit J; Sananpanichkul P; Suknikhom W; Bhamarapravatana K; Suwannarurk K; Leaungsomnapa Y
Asian Pac J Cancer Prev; 2016; 17(8):4163-7. PubMed ID: 27644678
[TBL] [Abstract][Full Text] [Related]
5. Do health care providers have a lower prevalence of abnormal pap smears than the general public?
Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S114-9. PubMed ID: 21294405
[TBL] [Abstract][Full Text] [Related]
6. Detecting premalignant cervical lesions. Contribution of screening colposcopy to cytology.
Davison JM; Marty JJ
J Reprod Med; 1994 May; 39(5):388-92. PubMed ID: 8064706
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of the Triple Test Versus Colposcopy for the Diagnosis of Premalignant and Malignant Cervical Lesions.
Fatahi Meybodi N; Karimi-Zarchi M; Allahqoli L; Sekhavat L; Gitas G; Rahmani A; Fallahi A; Hassanlouei B; Alkatout I
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3501-3507. PubMed ID: 33369445
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of abnormal Papanicolaou smears in female sex workers in Hong Kong.
Leung KM; Yeoh GP; Cheung HN; Fong FY; Chan KW
Hong Kong Med J; 2013 Jun; 19(3):203-6. PubMed ID: 23650200
[TBL] [Abstract][Full Text] [Related]
9. Implications regarding atypical squamous cells of undetermined significance among women residing in a US-Mexico border city.
Greenberg H; Duarte-Gardea M; Quezada OR
Int J Gynecol Cancer; 2006; 16(3):1014-6. PubMed ID: 16803478
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
[TBL] [Abstract][Full Text] [Related]
11. [The results of screening program for cervical cancer in Lodz].
Gottwald L; Giernat L; Lech W; Wójcik-Krowiranda K; Akoel KM; Kowalczyk-Amico K; Estemberg D; Grzesiak M; Sosnowski D; Guzowski G; Baś E; Tyliński W; Bieńkiewicz A
Ginekol Pol; 2002 Nov; 73(11):934-8. PubMed ID: 12722377
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cytopathological screening results and risk factors of women who underwent Papanicolaou test in a maternity school in Fortaleza, Ceará, Brazil.
Tavares MDC; Nicol AF; Yokobatake ER; Melo MML; Vitoriano BF; Carvalho-Costa FA; Martinelli KG; de Paula VS
Cytopathology; 2020 Nov; 31(6):586-592. PubMed ID: 32632990
[TBL] [Abstract][Full Text] [Related]
13. [Determinants of cellular atypia detection in the cervical screening program in Rio de Janeiro, Brazil].
da Silva MG; de Almeida RT; Bastos EA; Nobre FF
Rev Panam Salud Publica; 2013 Aug; 34(2):107-13. PubMed ID: 24096975
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
15. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
[TBL] [Abstract][Full Text] [Related]
16. Cervical Cancer Screening of Adolescents and Young Women: Further Evidence Shows a Lack of Clinical Value.
Campaner AB; Fernandes GL
J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):6-11. PubMed ID: 33130243
[TBL] [Abstract][Full Text] [Related]
17. Comparison of conventional and liquid-based Pap smear methods in the diagnosis of precancerous cervical lesions.
Honarvar Z; Zarisfi Z; Salari Sedigh S; Masoumi Shahrbabak M
J Obstet Gynaecol; 2022 Aug; 42(6):2320-2324. PubMed ID: 35579303
[TBL] [Abstract][Full Text] [Related]
18. [Verification of doubtful PAP smear results of women included in the screening program in the Podlaskie province].
Błońska E; Knapp PA
Ginekol Pol; 2013 Aug; 84(8):691-5. PubMed ID: 24191502
[TBL] [Abstract][Full Text] [Related]
19. [New guidelines in regard to cervical cancer screening].
Vargas-Hernández VM; Acosta-Altamirano G; Moreno-Eutimio MA; Vargas-Aguilar VM
Cir Cir; 2014; 82(4):453-9. PubMed ID: 25167359
[TBL] [Abstract][Full Text] [Related]
20. [Following-up females having an abnormal Pap smear in Colombia].
Wiesner C; Cendales R; Murillo R; Piñeros M; Tovar S
Rev Salud Publica (Bogota); 2010 Feb; 12(1):1-13. PubMed ID: 20628695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
